NO144488C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivaterInfo
- Publication number
- NO144488C NO144488C NO4652/72A NO465272A NO144488C NO 144488 C NO144488 C NO 144488C NO 4652/72 A NO4652/72 A NO 4652/72A NO 465272 A NO465272 A NO 465272A NO 144488 C NO144488 C NO 144488C
- Authority
- NO
- Norway
- Prior art keywords
- diisoprostanic
- preparation
- acid derivatives
- therapeutic activities
- analogy procedure
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT3252071 | 1971-12-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO144488B NO144488B (no) | 1981-06-01 |
NO144488C true NO144488C (no) | 1981-09-09 |
Family
ID=11235473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO4652/72A NO144488C (no) | 1971-12-17 | 1972-12-15 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US4089896A (ja) |
JP (1) | JPS5747188B2 (ja) |
AT (1) | AT340607B (ja) |
BE (1) | BE792803A (ja) |
CA (1) | CA999857A (ja) |
CH (1) | CH585197A5 (ja) |
CS (1) | CS174189B2 (ja) |
DE (1) | DE2261496A1 (ja) |
FR (1) | FR2163697B1 (ja) |
GB (1) | GB1420338A (ja) |
HU (1) | HU168381B (ja) |
IL (1) | IL41033A (ja) |
NL (1) | NL7217104A (ja) |
NO (1) | NO144488C (ja) |
SE (1) | SE415095B (ja) |
SU (2) | SU694069A3 (ja) |
ZA (1) | ZA728821B (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3975426A (en) * | 1972-09-15 | 1976-08-17 | The Upjohn Company | 8β, 11β, 12α-PGF2.sub.β -compounds |
US3969396A (en) * | 1972-09-15 | 1976-07-13 | The Upjohn Company | 8β, 11β, 12α-PGE2 compounds |
US4096342A (en) * | 1972-09-15 | 1978-06-20 | The Upjohn Company | 8β,12α,15β-PGE2 compounds |
US4024174A (en) * | 1973-12-25 | 1977-05-17 | Ono Pharmaceutical Company | Tranes-delta 2-prostaglandins |
DE4024345A1 (de) * | 1990-07-27 | 1992-01-30 | Schering Ag | Cyclopentenderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4100355A (en) * | 1972-09-15 | 1978-07-11 | The Upjohn Company | 8β,12α-PGE2 -type compounds |
-
0
- BE BE792803D patent/BE792803A/xx not_active IP Right Cessation
-
1972
- 1972-12-08 IL IL41033A patent/IL41033A/en unknown
- 1972-12-12 GB GB5733372A patent/GB1420338A/en not_active Expired
- 1972-12-12 ZA ZA728821A patent/ZA728821B/xx unknown
- 1972-12-15 SU SU721864310A patent/SU694069A3/ru active
- 1972-12-15 NL NL7217104A patent/NL7217104A/xx not_active Application Discontinuation
- 1972-12-15 SE SE7216401A patent/SE415095B/sv unknown
- 1972-12-15 AT AT1070872A patent/AT340607B/de not_active IP Right Cessation
- 1972-12-15 DE DE19722261496 patent/DE2261496A1/de not_active Withdrawn
- 1972-12-15 CH CH1835872A patent/CH585197A5/xx not_active IP Right Cessation
- 1972-12-15 FR FR7244818A patent/FR2163697B1/fr not_active Expired
- 1972-12-15 NO NO4652/72A patent/NO144488C/no unknown
- 1972-12-15 US US05/315,460 patent/US4089896A/en not_active Expired - Lifetime
- 1972-12-15 CA CA158,992A patent/CA999857A/en not_active Expired
- 1972-12-16 HU HU72EA119A patent/HU168381B/hu unknown
- 1972-12-18 CS CS8713A patent/CS174189B2/cs unknown
- 1972-12-18 JP JP47127058A patent/JPS5747188B2/ja not_active Expired
-
1975
- 1975-03-20 SU SU752113719A patent/SU626692A3/ru active
Also Published As
Publication number | Publication date |
---|---|
JPS4867257A (ja) | 1973-09-13 |
FR2163697B1 (ja) | 1978-02-10 |
HU168381B (en) | 1976-04-28 |
US4089896A (en) | 1978-05-16 |
AT340607B (de) | 1977-12-27 |
BE792803A (fr) | 1973-03-30 |
IL41033A0 (en) | 1973-02-28 |
SU626692A3 (ru) | 1978-09-30 |
IL41033A (en) | 1977-10-31 |
FR2163697A1 (ja) | 1973-07-27 |
CA999857A (en) | 1976-11-16 |
NO144488B (no) | 1981-06-01 |
CS174189B2 (ja) | 1977-03-31 |
DE2261496A1 (de) | 1973-06-20 |
ZA728821B (en) | 1973-09-26 |
NL7217104A (ja) | 1973-06-19 |
ATA1070872A (de) | 1977-04-15 |
SU694069A3 (ru) | 1979-10-25 |
GB1420338A (en) | 1976-01-07 |
JPS5747188B2 (ja) | 1982-10-07 |
SE415095B (sv) | 1980-09-08 |
CH585197A5 (ja) | 1977-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE385585B (sv) | Forfarande for framstellning av 1-alkyl-1,4-dihydro-4-oxo-3-kinolinkarboxylsyraderivat | |
SE395890B (sv) | Forfarande for framstellning av anthelmintiskt verksamma 2-karbalkoxiamino-bensimidazol-5 (6)-fenyletrar | |
SE398877B (sv) | Forfarande for framstellning av 14-hydroxi-morfinanderivat | |
NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
SE398229B (sv) | Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat | |
NO142173C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme, 1,1-diaryl-1-oksadiazolalkylaminderivater | |
NO143575C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater | |
NO143223C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,3-dimetyl-1h-pyrazol(3,4b)kinoliner | |
NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
SE397973B (sv) | Forfarande for framstellning av bensoylfenylsmorsyraderivat | |
NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
SE392615B (sv) | Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat | |
SE402009B (sv) | Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat | |
SE384686B (sv) | Forfarande for framstellning av linkomycinderivat | |
SE380527B (sv) | Forfarande for framstellning av 1oh-tieno(3,2-c)(1)-bensazepinderivat | |
SE386175B (sv) | Forfarande for framstellning av 1,4-bis-acylpiperaziner | |
NO144488C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater | |
SE408177B (sv) | Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat | |
NO137093C (no) | Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner | |
SE390025B (sv) | Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion | |
NO143845C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-amino-pyrrolderivater | |
SE405730B (sv) | Forfarande for framstellning av kinazolinderivat | |
SE397350B (sv) | Forfarande for framstellning av tieno-diazepinderivat |